Architects of Trust, led by Treatment Action Group, offers grants to civil society and community-based organizations in eligible high-TB-burden countries and regions to support advocacy, policy engagement, and community demand creation for new TB vaccines. Several new tuberculosis vaccines are advancing through late-stage clinical trials, with potential regulatory approval and policy recommendations as soon as
Access Restricted: Members-Only Content. We're sorry, but this content is available exclusively to our subscribed members: